S527Reported by Committee

Prescription Pricing for the People Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-02-11
Introduced
13
Cosponsors
S
ⓘ
Type

Sponsor

Chuck Grassley
Chuck Grassley
Republican · IA · Senator
Votes with party: 35.4% (322 recorded votes)

Full profile: /officials/G000386

Source: Congress.gov · FEC

Cosponsors (13)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.

2025-04-10

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would allow Medicare to negotiate drug prices directly with pharmaceutical companies, similar to how the Veterans Administration currently does, which could lower medication costs for seniors and other Medicare beneficiaries. The legislation aims to reduce what Americans pay for prescription drugs by giving the government more power to push back on high prices rather than accepting whatever price drug makers set. People on Medicare, their families, and potentially taxpayers would be affected, as lower drug costs could reduce both out-of-pocket expenses and government spending on healthcare.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Commerce
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.